ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $845,000 | -1.4% | 172,505 | 0.0% | 0.03% | 0.0% |
| Q3 2016 | $857,000 | -18.9% | 172,505 | 0.0% | 0.03% | +3.3% |
| Q2 2016 | $1,057,000 | -4.3% | 172,505 | 0.0% | 0.03% | -3.2% |
| Q1 2016 | $1,104,000 | +124.8% | 172,505 | -18.8% | 0.03% | +138.5% |
| Q4 2015 | $491,000 | -52.1% | 212,505 | 0.0% | 0.01% | -45.8% |
| Q3 2015 | $1,024,000 | -29.7% | 212,505 | 0.0% | 0.02% | -20.0% |
| Q2 2015 | $1,456,000 | -25.4% | 212,505 | -3.0% | 0.03% | -28.6% |
| Q1 2015 | $1,952,000 | -17.5% | 219,055 | -7.4% | 0.04% | -14.3% |
| Q4 2014 | $2,366,000 | -5.9% | 236,550 | -5.4% | 0.05% | +2.1% |
| Q3 2014 | $2,515,000 | +25.2% | 250,000 | 0.0% | 0.05% | +37.1% |
| Q2 2014 | $2,008,000 | -19.7% | 250,000 | 0.0% | 0.04% | -18.6% |
| Q1 2014 | $2,500,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 750,000 | $7,545,000 | 1.03% |
| WALL STREET ASSOCIATES | 475,100 | $4,780,000 | 0.49% |
| WASATCH ADVISORS LP | 1,158,344 | $11,653,000 | 0.12% |
| Pinnacle Summer Investments, Inc. | 92,415 | $929,000 | 0.10% |
| ALTRINSIC GLOBAL ADVISORS LLC | 250,000 | $2,515,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 25,811 | $260,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 22,704 | $228,000 | 0.03% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 701,900 | $7,061,000 | 0.02% |
| Alyeska Investment Group, L.P. | 79,430 | $799,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 500 | $5,000 | 0.01% |